NDC 0169-2550 – Tresiba
Insulin Degludec 200 U/mL · Injection, Solution · Subcutaneous
Product NDC0169-2550
Product details
- Brand name
- Tresiba
- Generic name
- Insulin degludec
- Labeler
- Novo Nordisk
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA203314
- Marketed since
- September 25, 2015
- Listing expires
- December 31, 2026
- Pharmacologic class
- Insulin Analog
Active ingredients
- Insulin Degludec 200 U/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0169-2550-13 | 3 SYRINGE, PLASTIC in 1 CARTON (0169-2550-13) / 3 mL in 1 SYRINGE, PLASTIC | Sep 25, 2015 |
| 0169-2550-97 | 1 SYRINGE, PLASTIC in 1 CARTON (0169-2550-97) / 3 mL in 1 SYRINGE, PLASTIC (0169-2550-90) | Sep 25, 2015 |
Recalls mentioning this NDC
- D-0620-2021 Apr 21, 2021 · Class I
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and… - D-0619-2021 Apr 21, 2021 · Class I
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and… - D-0621-2021 Apr 21, 2021 · Class I
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and…
Other Tresiba products
- 50090-3491 Insulin Degludec 200 U/mL · Injection, Solution · A-S Medication Solutions
- 50090-7094 Insulin Degludec 200 U/mL · Injection, Solution · A-S Medication Solutions
- 0169-2660 Insulin Degludec 100 U/mL · Injection, Solution · Novo Nordisk
- 0169-2662 Insulin Degludec 100 U/mL · Injection, Solution · Novo Nordisk